Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients

Clinical trial NCT03963921 · COMPLETED

Trial details

NCT number: NCT03963921
Sponsor: Cellaion SA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2019-04-09
Primary completion: 2020-05-28
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.